Prescription pain medications and chronic headache in Denmark: Implications for preventing medication overuse

European Journal of Clinical Pharmacology

Volumn 71, Issue 7, 2015, Pages 851-860

  Westergaard, Maria Lurenda ^a   Hansen, Ebba Holme ^b   Glümer, Charlotte ^a,c   Jensen, Rigmor Højland ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Analgesics; Chronic headache; Medication overuse headache; Opioids; Pharmacoepidemiology; Secondary headache disorders; Triptans

Indexed keywords

ANALGESIC AGENT; CODEINE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRAMADOL; TRIPTAN DERIVATIVE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG; TRYPTAMINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACKACHE; DENMARK; DISEASE ASSOCIATION; DRUG INDUCED HEADACHE; FEMALE; HUMAN; MALE; MIDDLE AGED; MIGRAINE; OSTEOARTHRITIS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VERY ELDERLY; YOUNG ADULT; CHEMICALLY INDUCED; CHRONIC PAIN; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DRUG UTILIZATION REVIEW; HEADACHE DISORDERS, SECONDARY; HEALTH CARE SURVEY; PRESCRIPTION DRUG OVERUSE; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ANALGESICS, OPIOID; CHRONIC PAIN; CROSS-SECTIONAL STUDIES; DENMARK; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HEADACHE DISORDERS, SECONDARY; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PRESCRIPTION DRUG OVERUSE; PRESCRIPTION DRUGS; RISK FACTORS; TIME FACTORS; TRYPTAMINES; YOUNG ADULT;

EID: 84930864732     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-015-1858-3     Document Type: Article

References (40)

1. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y (2003) Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 12:315-326. doi: 10.1002/pds.755
2. Saper JR, Sa Silva AN (2013) Medication overuse headache: history, features, prevention and management strategies. CNS Drugs 27:867-877. doi: 10.1007/s40263-013-0081-y
3. Munksgaard SB, Jensen RH (2014) Medication overuse headache. Headache 54:1251-1257. doi: 10.1111/head.12408
4. Kristoffersen ES, Lundqvist C (2014) Medication-overuse headache: a review. J Pain Res 7:367-368. doi: 10.2147/JPR.S46071
5. Westergaard ML, Glumer C, Hansen EH, Jensen RH (2014) Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position, and physical and mental health status. Pain 155:2005-2013. doi: 10.1177/0333102413512033
6. Lanteri-Minet M, Duru G, Mudge M, Cottrell S (2011) Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 31:837-850. doi: 10.1177/0333102411398400
7. Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, de la Torre ER, Tassorelli C, Barré J, Andrée C (2014) The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 15:31. doi: 10.1186/1129-2377-15-31
8. Russell MB, Lundqvist C (2012) Prevention and management of medication overuse headache. Curr Opin Neurol 25:290-295. doi: 10.1097/WCO.0b013e328352c431
9. Headache Classification Committee of the International Headache Society (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629-808. doi: 10.1177/0333102413485658
10. Jonsson P, Hedenrud T, Linde M (2011) Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 31:1015-1022. doi: 10.1177/0333102411410082
11. Da Silva AN, Lake AE III (2014) Clinical aspects of medication overuse headaches. Headache 54:211-217. doi: 10.1111/head.12223
12. Nielsen MW, Søndergaard B, Kjøller M, Hansen EH (2008) Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. J Clin Epidemiol 61:919-924. doi: 10.1016/j.jclinepi.2007.10.021
13. Hagen K, Lind M, Steiner TJ, Stovner LJ, Zart J-A (2012) Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag health studies. Pain 153:56-61. doi: 10.1016/j.pain.2011.08.018
14. Christensen AI, Ekholm O, Glümer C, Andreasen AH, Hvidberg MF, Kristensen PL, Larsen FB, Ortiz B, Juel K (2012) The Danish National Health Survey 2010. Study design and respondent characteristics. Scand J Public Health 40:391-397. doi: 10.1177/1403494812451412
15. Kildemoes HW, Sørensen HT, Hallas J (2011) The Danish national prescription registry. Scand J Public Healt 39(Suppl 7):38-41. doi: 10.1177/1403494810394717
16. WHO Collaborating Centre for Drug Statistics Methodology (2011) Use of ATC/DDD, www.whocc.no/use-of-atc-ddd (accessed 11 February 2015)
17. Pedersen CB (2011) The Danish civil registration system. Scand J Public Health 39(Suppl 7):22-25. doi: 10.1177/1403494810387965
18. Gaist D (1999) Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Cephalalgia 19:735-761
19. Von Euler M, Keshani S, Baatz K, Wettermark B (2014) Utilization of triptans in Sweden; analyses of over the counter and prescription sales. Pharmacoepidemiol Drug Saf 23:1288-1293. doi: 10.1002/pds.3681
20. 20 Bendtsen L, Birk S, Kasch H, Aegidius K, Sørensen PS, Thomsen LL, Poulsen L, Rasmussen MJ, Kruuse C, Jensen R (2012) Danish Headache Society. Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition. J Headache Pain 13 Suppl 1: S1-29. doi: 10.1007/s10194-011-0402-9
21. Franklin GM (2014) Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 83:1277-1284. doi: 10.1212/WNL.0000000000000839
22. Marmura MJ, Silberstein SD, Schwedt TJ (2015) The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache 55(1):3-20. doi: 10.1111/head.12499
23. Scher AI, Lipton RB, Stewart WF, Bigal M (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 30:321-328. doi: 10.1111/j.1468-2982.2009.01913.x
24. Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71:1821-1828. doi: 10.1212/01.wnl.0000335946.53860.1d
25. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011-1014
26. Orr SL, Aubé M, Becker WJ, Davenport WJ, Dilli E, Dodick D, Giammarco R, Gladstone J, Leroux E, Pim H, Dickinson G, Christie SN (2015) Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia 35:271-284. doi: 10.1177/0333102414535997
27. Kelley NE, Tepper DE (2012) Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications. Headache 52:467-482. doi: 10.1111/j.1526-4610.2012.02097.x
28. Robbins L (2004) Tramadol for tension-type headache. Headache 44(2):192-193
29. Ekholm O, Kurita GP, Højsted J, Juel K, Sjøgren P (2014) Chronic pain, opioid prescriptions, and mortality in Denmark: a population-based cohort study. Pain 155(12):2486-2490. doi: 10.1016/j.pain.2014.07.006
30. Fredheim OMS, Skurtveit S, Moroz A, Breivik H, Borchgrevink PC (2009) Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database. Acta Anaesthesiol Scand 53:627-633
31. Le H, Tfelt-Hansen P, Skytthe A, Kyvik KO, Olesen J (2012) Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal population-based study. BMJ Open 2. doi: 10.1136/bmjopen-2012-000962
32. Antonaci F, Dumitrache C, De Cillis I et al (2010) A review of current European treatment guidelines for migraine. J Headache Pain 11:13-19. doi: 10.1007/s10194-009-0179-2
33. Bigal ME, Borucho S, Serrano D, Lipton RB (2009) The acute treatment of episodic and chronic migraine in the USA. Cephalalgia 29:891-897. doi: 10.1111/j.1468-2982.2008.01819.x
34. Wells RE, Markowitz SY, Barton EP, Hentz JG, Kalidas K, Mathew PG, Halker R, Dodick DW, Schwedt TJ (2014) Identifying the factors underlying discontinuation of triptans. Headache 54:278-289. doi: 10.1111/head.12198
35. Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC (2015) Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology 84:688-695. doi: 10.1212/WNL.0000000000001256
36. Tfelt-Hansen PC, Koehler PJ (2008) History of the use of ergotamine and dihydroergotamine in migraine from 1906 onward. Cephalalgia 28:877-886. doi: 10.1111/j.1468-2982.2008.01578.x
37. Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic headache arise de novo in association with regular use of analgesics? Headache 43:179-190. doi: 10.1046/j.1526-4610.2003.03041.x
38. Yoon MS, Manack A, Schramm S, Fritsche G, Obermann M, Diener HC, Moebus S, Katsarava Z (2013) Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: results of the German Headache Consortium Study. Pain 154(3):484-492. doi: 10.1016/j.pain.2012.12.010
39. Johnson JL, Hutchinson MR, Williams DB, Rolan P (2013) Medication-overuse headache and opioid-induced hyperalgesia: a review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment. Cephalalgia 33(1):52-64. doi: 10.1177/0333102412467512
40. Langhammer A, Krokstad S, Romundstad P, Heggland J, Holmen J (2012) The HUNT study: participation is associated with survival and depends on socioeconomic status, diseases and symptoms. BMC Med Res Methodol 12:143. doi: 10.1186/1471-2288-12-143